TY - JOUR T1 - The percentages of usage of phosphodiesterase 5 inhibitors for the first-line treatment in patients with erectile dysfunction AU - Sancı, Adem AU - Özcan, Cihat Y1 - 2022 PY - 2022 DA - 2022 N1 - doi: 10.24898/tandro.2022.78095 DO - 10.24898/tandro.2022.78095 T2 - Andrology Bulletin JF - Andrology Bulletin JO - SP - 167 EP - 171 VL - 24 IS - 3 SN - M3 - doi: 10.24898/tandro.2022.78095 UR - https://dx.doi.org/10.24898/tandro.2022.78095 Y2 - 2022 ER -